Responses
Clinical and epidemiological research
Extended report
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry
Compose a Response to This Article
Other responses
No responses have been published for this article.